Abstract:In the title compound, C20H25NO5, the dihydropyridine ring adopts a flattened boat conformation. The methoxyphenyl ring is almost perpendicular to the mean plane of the pyridine ring [dihedral angle = 88.42 (3)degrees]. The two carbonyl units adopt a synperiplanar conformation with respect to the double bonds in the dihydropyridine ring. In the crystal, molecules are connected by N-H center dot center dot center dot O hydrogen bonds into R-4(4) (24) tetrameric rings. A region of disordered electron density, located at the center of four adjacent molecules, was treated with the SQUEEZE routine in PLATON [Spek (2009). Acta Cryst. D65, 148-155]. It is probably the result of traces of the solvent of crystallization and was not taken into account during the structure refinement.

1-Ethoxymethyl-5-Methyl-9-Phenyl-6,7,8,9-Tetrahydro-1h-Pyrimido[4,5-B][1 ,4]Diazepine-2,4(3h, 5h)-Dione

1,3A,5-Triphenyl-3a,4,5,6-tetrahydro-1,2,4-oxadiazolo[4,5-a][1,5]benzodiazepine

Ethyl 1-[6-(Dimethylamino)pyridazin-3-yl]-5-methyl-1h-pyrazole-4-carboxylate

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

(4Z)-4-[(4-methoxybenzylamino)(phenyl)methylene]-3-methyl-1-phenyl-1h-pyrazol-5(4h)-one

1,5-Dimethyl-2-phenyl-4-{[(E)-3,4,5-trimethoxybenzylidene]amino}-1H-pyrazol-3(2H)-one.

1,1′,5,5′-Tetramethyl-2,2′-diphenyl-4,4′-[p-phenylenebis(methylidynenitrilo)]di-1H-pyrazol-3(2H)-one

(4Z)-4-[(Cyclopropylamino)(phenyl)methylene]-3-methyl-1-phenyl-1H-pyrazol- 5(4H)-one

Ethyl 3-Methyl-6-oxo-5-[3-(trifluoromethyl)phenyl]-1,6-dihydro-1-pyridazineace Tate

1,1′,5,5′-Tetramethyl-2,2′-diphenyl-4, 4′-[p-phenylenebis(methylidynenitrilo)]di-1H-pyrazol-3(2H)-one

Diethyl 4-(2-Methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

(8S)-3-(2-Deoxy-3,5-di-O-p-toluoyl-α-D-erythro-pentofuranosyl)-3,6,7, 8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol

(8S)-3-(2-deoxy-3,5-di-o-p-toluoyl-alpha-d-erythro-pentofuranosyl)-3,6,7 ,8-Tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol

5-Methyl-1,2,3,3a-tetrahydrobenzo[e]pyrrolo[2,1-b][1,3]oxazepin-10(5h)-one

(S)-N-(1h-tetrazol-5-ylmethyl)pyrrolidine-2-carboxamide Dihydrate

6,7-Dihydro-4-(4-methoxyphenyl)-3-methyl-6-oxo-1-phenyl-1h-pyrazolo[3,4-b]pyridine-5-carbonitrile

2-[3-(Trifluoromethyl)phenyl]perhydro1,2,4-triazolo[1,2-a]pyridazine-1,3 -Dione

3-(imidazolidin-2-ylidene)-6-methyl-3,4,5,6-tetrahydro-2H-pyran-2,4-dione

5-P-tolyl-1,2,3,3a-tetra-hydro-benzo[e]pyrrolo-[2,1-b][1,3]oxazepin-10(5h)-one.

1-(3-Chlorobenzyl)pyrimidine-2,4(1h,3h)-dione

Ethyl 3-(Anilinocarbonothioyl)-6-methyl-2,4-diphenyl-1,2,3,4-tetrahydropyrimid Ine-5-Carboxylate